Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.11, moving +1.63% from the previous trading session. The stock's performance was ahead of the S&P 500's daily gain of 0.11%.

How doors, keys, and backtracking unlocked survival horror.

SPDR S&P Biotech ETF (NYSEARCA:XBI) is built around a deceptively simple idea: give every biotech company roughly equal footing, regardless of size. That equal-weight structure separates it from ...

CoinDesk Research maps five crypto privacy approaches and examines which models hold up as AI improves. Full coverage of ...

On the buying side, ARK made a significant purchase of 60,973 shares of Tempus AI Inc (TEM), investing $2,851,097. This ...

In Trend’s view, art is love’s lasting archive, turning fleeting desire into a form that endures long after the heart that ...

While millennials dissect every feeling in £80 therapy sessions, their grandparents built the exact same coping mechanisms ...

The Kill Chain models how an attack succeeds. The Attack Helix models how the offensive baseline improves. Tipping Points One person. Two AI subscriptions. Ten government agencies. 150 gigabytes of ...

Why the enterprise architect’s most important job in 2026 isn’t designing systems—it’s governing the agents that design ...

Examines how AI agent delegation enables risks like session smuggling and escalation, with defenses such as scoped ...

Relying on one giant AI model for everything is a trap; it’s too expensive and slow for simple tasks and too risky for the ...

ARK Invest sold $84M in Meta, Nvidia, AMD, and chip stocks on March 26, 2026. See why Cathie Wood trimmed big tech and what ...